Riskpilot← Back to searchSign inGet full accessSuubi AB
ABActiveOrg 5591782494Backvindeln 25Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 9K
-97% vs 2024
EBITDA margin
-412.7%
-122% vs 2024
Equity ratio
-70.2%
Financial strength
Net profit 2025
SEK -37K
-123% vs 2024
| Revenue | SEK 9K | -97% |
| EBITDA | SEK -37K | -122% |
| Net profit | SEK -37K | -123% |
| Total assets | SEK 17K | -92% |
| Equity | SEK -12K | -111% |
| Employees | 1 | — |
Legal name
Suubi AB
Org number
5591782494
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 november 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva psykiatri, konsultation samt föreläsningar inom hälso- och sjukvård samt därmed förenlig verksamhet. Bolaget kommer därutöver bedriva konsultation inom management, företagsledning och styrelsearbete. Bolaget ska även handla med värdepapper samt andra placeringar inom den finansiella sektorn och därmed förenlig verksamhet.
Address
Backvindeln 25
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 917 | 762 | 136 | 281 | 9 |
| Staff expenses | — | −1 235 | −75 | −61 | −23 |
| EBITDA | 34 | −589 | −59 | 166 | −37 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 34 | −589 | −59 | 166 | −37 |
| Net financials | −1 | −6 | 0 | −2 | 0 |
| Profit before tax | 33 | −594 | −59 | 164 | −37 |
| Tax | −7 | — | — | — | — |
| Net profit | 26 | −594 | −59 | 164 | −37 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 894 | 632 | 166 | 218 | 17 |
| Equity | 299 | 105 | 46 | 110 | −12 |
| Long-term debt | 1 439 | 393 | 13 | 14 | 1 |
| Short-term debt | 156 | 134 | 106 | 93 | 28 |
| Total debt | 1 595 | 527 | 120 | 107 | 28 |
EBITDA margin
-412.7%
This company
15.8%
Market median
-2712% vs market
20212025
Equity ratio
-70.2%
This company
38.2%
Market median
-284% vs market
20212025
Return on equity
-3712400.0%
This company
18.4%
Market median
-20176187% vs market
20212025
Net profit margin
-412.4%
This company
8.1%
Market median
-5191% vs market
20212025
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20212025
Debt / equity
2.42×
This company
0.62×
Market median
-290% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Suubi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ruth Mabikke Bohlin | Board of Directors | 0 companies |
| Elizabeth Suzana Makumbi Brandsen | Deputy Board Member | 0 companies |